Outcomes after Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.

International Journal of Radiation Oncology*Biology*Physics(2019)

引用 19|浏览63
暂无评分
摘要
We observe excellent outcomes in patients treated with PRT for HR-NBL from 2010-2015, with 82% of patients alive and 97% free of primary site recurrence. No patient has experienced long-term renal or liver toxicity. This treatment maximizes normal tissue preservation and is appropriate for this patient population.
更多
查看译文
关键词
Neuroblastoma,high-risk neuroblastoma,proton therapy,radiation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要